GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 87660522
Serial Number
87660522
Registration Number
6396881
Word Mark
GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT
Status
700 - Registered
Status Date
2021-06-22
Filing Date
2017-10-26
Registration Number
6396881
Registration Date
2021-06-22
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
010905, 100901, 261126, 261901 - Atoms or molecular models. Medicines and nonmedical products in tablet, capsule or powder form; suppositories. Oblongs as carriers for words, letters or designs. Spheres.
Published for Opposition Date
2020-03-17
Attorney Name
Arnold Braun
Law Office Assigned Location Code
L60
Employee Name
HETZEL, DANNEAN
Statements
Indication of Colors claimed
The color(s) red, black, white, gray and gold is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"DRUG DISCOVERY & DEVELOPMENT"
Description of Mark
The mark consists of the wording "GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT" and a design. The letters "G" and "D" are depicted inside a bisected oblong shape representing a pill. The letter "G" is in white with an outline in various shades of red. The letter "D" is in white with an outline in various shades of grey. The left half of the pill design with the letter "G" is in various shades of red. The right side of the pill design with the letter "D" is in various shades of grey. The number "3" is depicted in red with a white outline inside a stylized depiction of a molecule located to the upper right of the "GD" lettering. The molecule consists of four gold spheres representing atoms, which are connected by three straight bands in various shades of grey representing bonds. The stylized wording "GENESIS" appears in red below the "GD" lettering and pill design. The stylized wording "DRUG DISCOVERY & DEVELOPMENT" appears in smaller black font below the wording "GENESIS".
Goods and Services
Scientific study and research in the fields of medicine, the prevention and treatment of illness, drug screening, mode of action of medicines in animal models, and pharmacokinetic evaluation and preclinical evaluation of lead compounds in drug discovery
Pseudo Mark
GD THREE GENESIS DRUG DISCOVERY AND DEVELOPMENT
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2017-11-04
Primary Code
042
First Use Anywhere Date
2017-00-00
First Use In Commerce Date
2017-00-00
Current Trademark Owners
Party Name
Genesis Drug Discovery & Development, LLC
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Genesis Drug Discovery & Development, LLC
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Genesis Drug Discovery & Development, LLC
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Genesis Drug Discovery & Development, LLC
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Arnold Braun
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2017-10-30NEW APPLICATION ENTERED IN TRAM
2017-11-04NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2017-11-07NOTICE OF DESIGN SEARCH CODE E-MAILED
2018-02-06ASSIGNED TO EXAMINER
2018-02-21NON-FINAL ACTION WRITTEN
2018-02-21NON-FINAL ACTION E-MAILED
2018-02-21NOTIFICATION OF NON-FINAL ACTION E-MAILED
2018-08-17TEAS RESPONSE TO OFFICE ACTION RECEIVED
2018-08-17CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-08-18TEAS/EMAIL CORRESPONDENCE ENTERED
2018-09-06SUSPENSION LETTER WRITTEN
2018-09-06LETTER OF SUSPENSION E-MAILED
2018-09-06NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2019-03-26ASSIGNED TO LIE
2019-03-28REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
2019-10-10LIE CHECKED SUSP - TO ATTY FOR ACTION
2019-11-01FINAL REFUSAL WRITTEN
2019-11-01FINAL REFUSAL E-MAILED
2019-11-01NOTIFICATION OF FINAL REFUSAL EMAILED
2020-01-14TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-01-14ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-02-03TEAS REQUEST FOR RECONSIDERATION RECEIVED
2020-02-03CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-02-04TEAS/EMAIL CORRESPONDENCE ENTERED
2020-02-10APPROVED FOR PUB - PRINCIPAL REGISTER
2020-02-26NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-03-17PUBLISHED FOR OPPOSITION
2020-03-17OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-05-12NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2020-10-16TEAS STATEMENT OF USE RECEIVED
2020-10-31CASE ASSIGNED TO INTENT TO USE PARALEGAL
2020-10-16USE AMENDMENT FILED
2020-10-31STATEMENT OF USE PROCESSING COMPLETE
2020-11-02SU - NON-FINAL ACTION - WRITTEN
2020-11-02NON-FINAL ACTION E-MAILED
2020-11-02NOTIFICATION OF NON-FINAL ACTION E-MAILED
2021-04-21TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-04-28CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-04-28TEAS/EMAIL CORRESPONDENCE ENTERED
2021-04-30ASSIGNED TO EXAMINER
2021-05-17ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2021-05-18NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2021-06-22REGISTERED-PRINCIPAL REGISTER